Back
NovaBay Pharmaceuticals Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
17
NBY
NovaBay Pharmaceuticals
Last Price:
$0.48
Seasonality Move:
-10.51%
7 Day Trial
ALL ACCESS PASS
$
7
He's already IPO'd once - this time's different
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Buy |
| 20-day SMA: | 0.58 | Sell |
| 50-day SMA: | 0.61 | Sell |
| 200-day SMA: | 0.79 | Sell |
| 8-day EMA: | 0.52 | Buy |
| 20-day EMA: | 0.56 | Sell |
| 50-day EMA: | 0.6 | Sell |
| 200-day EMA: | 2.59 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.9 | Sell |
| Chaikin Money Flow: | 29239 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.53 - 0.63) | Sell |
| Bollinger Bands (100): | (0.55 - 0.69) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.53 while NBY 8-day simple moving average is 0.52, which is a Buy signal.
-
The stock price of NBY is 0.53 while NovaBay Pharmaceuticals 20-day SMA is 0.58, which makes it a Sell.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.61 while NBY share price is 0.53, making it a Sell technically.
-
NBY stock price is 0.53 and NovaBay Pharmaceuticals 200-day simple moving average is 0.79, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
17
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.1M
Price in USD:
0.53
Share Volume:
29.4K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
9.08
52-Week Low:
0.36
Sell
17
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.53 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.53 while NBY 8-day exponential moving average is 0.52, which is a Buy signal.
-
The stock price of NBY is 0.53 while NovaBay Pharmaceuticals 20-day EMA is 0.56, which makes it a Sell.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.60 while NBY share price is 0.53, making it a Sell technically.
-
NBY stock price is 0.53 and NovaBay Pharmaceuticals 200-day simple moving average is 2.59, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting NovaBay Pharmaceuticals is a Sell
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 41.9, which suggest NovaBay Pharmaceuticals is oversold
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.53 - 0.63), which suggest NovaBay Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.55 - 0.69), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.